{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:42:39Z","timestamp":1785426159270,"version":"3.56.0"},"reference-count":30,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"unspecified","delay-in-days":160,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ASHE"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S2732494X26107505_as1\">\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study examined stakeholder perceptions of gaps in antimicrobial resistance (AMR) mitigation efforts across different sectors and career stages, with the goal of generating insights to support prioritization of One Health interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2732494X26107505_as2\">\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>We conducted a cross-sectional survey of AMR stakeholders using a structured questionnaire between October and November 2025. Stakeholders were recruited through international networks across 33 countries on 5 continents. Respondents listed the top three areas in AMR mitigation efforts that they perceived as receiving insufficient attention but require greater focus to reduce the emergence and spread of drug-resistant bacterial infections. We performed thematic analysis, calculated weighted priority scores, conducted an Impact-Effort Matrix analysis, and applied Fisher\u2019s exact tests to examine associations between themes, professional sector and career stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2732494X26107505_as3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 103 respondents, participants spanned nine professional sectors and four career stages. Antimicrobial stewardship (18.8%, weighted score 119) and Environmental AMR and Waste (16.5%, weighted score 108) were the most frequently cited perceived gaps. Impact-Effort Matrix analysis identified four priority areas as Quick Wins (stewardship, IPC, surveillance, and animal health, accounting for 45.7% of impact), two Major Projects (environmental AMR, R&amp;D), three Fill-ins (awareness, One Health, other\/cross-cutting), and three Hard Slogs (access, financing, policy). No significant associations were observed between perceived mitigation gaps across professional sector and career stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2732494X26107505_as4\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The emphasis on antimicrobial stewardship among stakeholders highlights a perceived disconnect between stewardship policy adoption and on-the-ground practice. The Impact-Effort Matrix provides a decision-support tool that may assist policymakers and funders in prioritizing One Health interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/ash.2026.10750","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:05:02Z","timestamp":1781064302000},"source":"Crossref","is-referenced-by-count":0,"title":["Stakeholder perceptions of gaps in antimicrobial resistance mitigation: a multinational multisectoral survey to inform prioritization of One Health interventions"],"prefix":"10.1017","volume":"6","author":[{"given":"Godwin Pius","family":"Ohemu","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0405mnx93","id-type":"ROR","asserted-by":"publisher"}],"name":"Texas Tech University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7720-4357","authenticated-orcid":false,"given":"Howard","family":"Rodriguez-Mori","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0405mnx93","id-type":"ROR","asserted-by":"publisher"}],"name":"Texas Tech University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Schmidt","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0405mnx93","id-type":"ROR","asserted-by":"publisher"}],"name":"Texas Tech University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4779-6515","authenticated-orcid":false,"given":"Babafela","family":"Awosile","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0405mnx93","id-type":"ROR","asserted-by":"publisher"}],"name":"Texas Tech University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"S2732494X26107505_ref30","first-page":"CD011086","article-title":"Implementation strategies for health systems in low-income countries: an overview of systematic reviews","volume":"9","author":"Pantoja","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"S2732494X26107505_ref3","volume-title":"Antibiotic Resistance Threats in the United States, 2019","year":"2019"},{"key":"S2732494X26107505_ref25","volume-title":"Global Antimicrobial Resistance and use Surveillance System (GLASS) Report 2022","year":"2022"},{"key":"S2732494X26107505_ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.71077"},{"key":"S2732494X26107505_ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3439"},{"key":"S2732494X26107505_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.08.001"},{"key":"S2732494X26107505_ref5","volume-title":"Global Call to Action to Address Antimicrobial Resistance: An Appeal for Keeping Our Medicines against Infectious Diseases Effective to Save Lives","year":"2025"},{"key":"S2732494X26107505_ref17","volume-title":"Implementing the Global Action Plan on Antimicrobial Resistance: First Quadripartite Biennial Report","year":"2024"},{"key":"S2732494X26107505_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(24)00277-8"},{"key":"S2732494X26107505_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2024.100081"},{"key":"S2732494X26107505_ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.47790"},{"key":"S2732494X26107505_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"S2732494X26107505_ref7","volume-title":"Global Antibiotic Resistance Surveillance Report 2025","year":"2025"},{"key":"S2732494X26107505_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2024.10.082"},{"key":"S2732494X26107505_ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-022-01209-4"},{"key":"S2732494X26107505_ref20","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2021.480"},{"key":"S2732494X26107505_ref21","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14080764"},{"key":"S2732494X26107505_ref6","volume-title":"One Health Joint Plan of Action (2022\u20132026): Working Together for the Health of Humans, Animals, Plants and the Environment","year":"2022"},{"key":"S2732494X26107505_ref27","volume-title":"Antimicrobial Stewardship Programmes in Health-Care Facilities in Low- and Middle-Income Countries: A WHO Practical Toolkit","year":"2019"},{"key":"S2732494X26107505_ref26","doi-asserted-by":"publisher","DOI":"10.1080\/17441692.2021.2003839"},{"key":"S2732494X26107505_ref13","doi-asserted-by":"publisher","DOI":"10.1097\/pq9.0000000000000519"},{"key":"S2732494X26107505_ref14","volume-title":"WHO Implementation Handbook for National Action Plans on Antimicrobial Resistance: Guidance for the Human Health Sector","year":"2022"},{"key":"S2732494X26107505_ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-025-01524-7"},{"key":"S2732494X26107505_ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1123189"},{"key":"S2732494X26107505_ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit212"},{"key":"S2732494X26107505_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S2542-5196(17)30141-9"},{"key":"S2732494X26107505_ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-10404-y"},{"key":"S2732494X26107505_ref29","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8040252"},{"key":"S2732494X26107505_ref4","volume-title":"Global Action Plan On Antimicrobial Resistance","year":"2015"},{"key":"S2732494X26107505_ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-022-01130-x"}],"container-title":["Antimicrobial Stewardship &amp; Healthcare Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2732494X26107505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:05:06Z","timestamp":1781064306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2732494X26107505\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"alternative-id":["S2732494X26107505"],"URL":"https:\/\/doi.org\/10.1017\/ash.2026.10750","relation":{},"ISSN":["2732-494X"],"issn-type":[{"value":"2732-494X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e174"}}